| Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations H Senta, H Park, E Bergeron, O Drevelle, D Fong, E Leblanc, F Cabana, ... Cytokine & Growth Factor Reviews 20 (3), 213-222, 2009 | 159 | 2009 |
| BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment E Leblanc, F Trensz, S Haroun, G Drouin, É Bergeron, CM Penton, ... Journal of Bone and Mineral Research 26 (6), 1166-1177, 2011 | 129 | 2011 |
| Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres E Bergeron, ME Marquis, I Chretien, N Faucheux Journal of Materials Science: Materials in Medicine 18 (2), 255-263, 2007 | 106 | 2007 |
| Bone cells-biomaterials interactions ME Marquis, E Lord, E Bergeron, O Drevelle, H Park, F Cabana, H Senta, ... Frontiers in Bioscience 14 (3), 1023-1067, 2009 | 96 | 2009 |
| Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9 E Bergeron, H Senta, A Mailloux, H Park, E Lord, N Faucheux Tissue Engineering Part A 15 (11), 3341-3349, 2009 | 77 | 2009 |
| Bone repair: New developments in growth factor delivery systems and their mathematical modeling MA Lauzon, É Bergeron, B Marcos, N Faucheux Journal of Controlled Release 162 (3), 502-520, 2012 | 73 | 2012 |
| Gold nanoparticle-assisted all optical localized stimulation and monitoring of Ca2+ signaling in neurons F Lavoie-Cardinal, C Salesse, E Bergeron, M Meunier, P De Koninck Scientific Reports 6, 20619, 2016 | 68 | 2016 |
| Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways H Park, E Bergeron, H Senta, K Guillemette, S Beauvais, R Blouin, ... Biochemical and Biophysical Research Communications 399 (3), 446-451, 2010 | 67 | 2010 |
| Hyperspectral reflected light microscopy of plasmonic Au/Ag alloy nanoparticles incubated as multiplex chromatic biomarkers with cancer cells S Patskovsky, E Bergeron, D Rioux, M Simard, M Meunier Analyst 139 (20), 5247–5253, 2014 | 66 | 2014 |
| Wide‐field hyperspectral 3D imaging of functionalized gold nanoparticles targeting cancer cells by reflected light microscopy S Patskovsky, E Bergeron, D Rioux, M Meunier Journal of Biophotonics 8 (5), 401-407, 2015 | 59 | 2015 |
| Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles E Bergeron, C Boutopoulos, R Martel, A Torres, C Rodriguez, J Niskanen, ... Nanoscale 7 (42), 17836-17847, 2015 | 58 | 2015 |
| The evaluation of ectopic bone formation induced by delivery systems for bone morphogenetic protein-9 or its derived peptide E Bergeron, E Leblanc, O Drevelle, R Giguère, S Beauvais, G Grenier, ... Tissue Engineering Part A 18 (3-4), 342-352, 2012 | 58 | 2012 |
| Hyperspectral darkfield microscopy of PEGylated gold nanoparticles targeting CD44‐expressing cancer cells S Patskovsky, E Bergeron, M Meunier Journal of Biophotonics 8 (1-2), 162-167, 2015 | 56 | 2015 |
| Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts O Drevelle, E Bergeron, H Senta, MA Lauzon, S Roux, G Grenier, ... Biomaterials 31 (25), 6468-6476, 2010 | 43 | 2010 |
| Cell perforation mediated by plasmonic bubbles generated by a single near infrared femtosecond laser pulse C Boutopoulos, E Bergeron, M Meunier Journal of Biophotonics 9 (1-2), 26-31, 2016 | 33 | 2016 |
| Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9 ME Marquis, E Lord, E Bergeron, L Bourgoin, N Faucheux Biomaterials 29 (8), 1005-1016, 2008 | 26 | 2008 |
| Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach D Hubmacher, E Bergeron, C Fagotto-Kaufmann, LY Sakai, DP Reinhardt Biomacromolecules 15 (4), 1456-1468, 2014 | 25 | 2014 |
| Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes E Lord, E Bergeron, H Senta, H Park, N Faucheux Growth Factors 28 (3), 149-156, 2010 | 23 | 2010 |
| Combination of synthetic peptides derived from bone morphogenetic proteins and biomaterials for medical applications H Senta, E Bergeron, O Drevelle, H Park, N Faucheux The Canadian Journal of Chemical Engineering 89 (2), 227-239, 2011 | 19 | 2011 |
| Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9 H Park, O Drevelle, A Daviau, H Senta, E Bergeron, N Faucheux Anti-Cancer Drugs 24 (3), 278-290, 2013 | 15 | 2013 |
Etienne LordResearcher in Digital Agronomy at AAFCVerified email at agr.gc.ca
